VIDAZA Drug Use Examination

Trial Profile

VIDAZA Drug Use Examination

Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Myelodysplastic syndromes
  • Focus Adverse reactions
  • Sponsors Celgene Corporation
  • Most Recent Events

    • 24 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 15 Jan 2016 Planned End Date changed from 1 Nov 2016 to 1 May 2016 according to
    • 15 Jan 2016 Planned primary completion date changed from 1 Aug 2016 to 1 May 2016 according to
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top